Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Risk factors for the development of interstitial lung disease following severe COVID-19 pneumonia and outcomes of systemic corticosteroid therapy: 3-month follow-up.
Sarcoidosis Vasc Diffuse Lung Dis. 2023 Sep 13;40(3):e2023029. doi: 10.36141/svdld.v40i3.14418.
Sarcoidosis Vasc Diffuse Lung Dis. 2023.
PMID: 37712369
Free PMC article.
Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patients.
Kilic H, Arguder E, Karalezli A, Unsal E, Guner R, Kayaslan B, Hasanoglu İ, Ates İ, Civak M, Akpınar E, Parlak E, Sadi F, Kocaman Y, Günay S, Metan E, Er M, Dalkıran A, Hezer H, Ergüden H, Hancıoğlu Z, Kalem A, Eser F, Aypak A, Akıncı E, Karahmetoğlu S, Gemcioglu E, Kalkan E, İnan O, Yilmaz A, Güler B, Çopuroğlu E, Turan İ, Gökmen D, Hayme S, Surel AA.
Kilic H, et al. Among authors: hancioglu z.
Front Med (Lausanne). 2022 Oct 13;9:957598. doi: 10.3389/fmed.2022.957598. eCollection 2022.
Front Med (Lausanne). 2022.
PMID: 36314036
Free PMC article.
Item in Clipboard
Cite
Cite